These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29557190)

  • 1. Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project.
    Brislin SJ; Patrick CJ; Flor H; Nees F; Heinrich A; Drislane LE; Yancey JR; Banaschewski T; Bokde ALW; Bromberg U; Büchel C; Quinlan EB; Desrivières S; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Martinot JL; Martinot MP; Papadopoulos Orfanos D; Poustka L; Fröhner JH; Smolka MN; Walter H; Whelan R; Conrod P; Stringaris A; Struve M; van Noort B; Grimmer Y; Fadai T; Schumann G; Foell J
    Assessment; 2019 Jun; 26(4):567-581. PubMed ID: 29557190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A construct-network approach to bridging diagnostic and physiological domains: application to assessment of externalizing psychopathology.
    Patrick CJ; Venables NC; Yancey JR; Hicks BM; Nelson LD; Kramer MD
    J Abnorm Psychol; 2013 Aug; 122(3):902-16. PubMed ID: 24016026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a co-twin control design to evaluate alternative trait measures as indices of liability for substance use disorders.
    Joyner KJ; Yancey JR; Venables NC; Burwell SJ; Iacono WG; Patrick CJ
    Int J Psychophysiol; 2020 Feb; 148():75-83. PubMed ID: 31857192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and initial validation of the disinhibition inventory: a multifaceted measure of disinhibition.
    Dindo L; McDade-Montez E; Sharma L; Watson D; Clark LA
    Assessment; 2009 Sep; 16(3):274-91. PubMed ID: 19228581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing general versus specific liability for externalizing problems in adolescence: Concurrent and prospective prediction of symptoms of conduct disorder, ADHD, and substance use.
    Perkins ER; Joyner KJ; Foell J; Drislane LE; Brislin SJ; Frick PJ; Yancey JR; Soto EF; Ganley CM; Keel PK; Sica C; Flor H; Nees F; Banaschewski T; Bokde ALW; Desrivières S; Grigis A; Garavan H; Gowland P; Heinz A; Ittermann B; Martinot JL; Paillère Martinot ML; Artiges E; Papadopoulos Orfanos D; Poustka L; Hohmann S; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; The Imagen Consortium ; Patrick CJ
    J Psychopathol Clin Sci; 2022 Oct; 131(7):793-807. PubMed ID: 36222627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A shared neural basis underlying psychiatric comorbidity.
    Xie C; Xiang S; Shen C; Peng X; Kang J; Li Y; Cheng W; He S; Bobou M; Broulidakis MJ; van Noort BM; Zhang Z; Robinson L; Vaidya N; Winterer J; Zhang Y; King S; Banaschewski T; Barker GJ; Bokde ALW; Bromberg U; Büchel C; Flor H; Grigis A; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Martinot JL; Martinot MP; Nees F; Orfanos DP; Paus T; Poustka L; Fröhner JH; Schmidt U; Sinclair J; Smolka MN; Stringaris A; Walter H; Whelan R; Desrivières S; Sahakian BJ; Robbins TW; Schumann G; Jia T; Feng J; ; ;
    Nat Med; 2023 May; 29(5):1232-1242. PubMed ID: 37095248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Personality Inventory for ICD-11: Investigating reliability, structural and concurrent validity, and method variance.
    Carnovale M; Sellbom M; Bagby RM
    Psychol Assess; 2020 Jan; 32(1):8-17. PubMed ID: 31556679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of the Health of the Nation Outcome Scales as measures of clinical severity.
    Müller M; Vandeleur C; Weniger G; Prinz S; Vetter S; Egger ST
    Psychiatry Res; 2016 May; 239():20-7. PubMed ID: 27137958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural signatures of data-driven psychopathology dimensions at the transition to adolescence.
    Modabbernia A; Michelini G; Reichenberg A; Kotov R; Barch D; Frangou S
    Eur Psychiatry; 2022 Jan; 65(1):e12. PubMed ID: 35067249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.
    Iacono WG; Malone SM; McGue M
    Int J Psychophysiol; 2003 May; 48(2):147-78. PubMed ID: 12763572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of clinician-reported ICD-11 personality disorder trait qualifiers.
    Bach B; Christensen S; Kongerslev MT; Sellbom M; Simonsen E
    Psychol Assess; 2020 Jan; 32(1):50-59. PubMed ID: 31328934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrative Analysis of the Narcissistic Personality Inventory and the Hypomanic Personality Scale: Implications for Construct Validity.
    Stanton K; Daly E; Stasik-O'Brien SM; Ellickson-Larew S; Clark LA; Watson D
    Assessment; 2017 Sep; 24(6):695-711. PubMed ID: 26773802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The difference between trait disinhibition and impulsivity-and why it matters for clinical psychological science.
    Joyner KJ; Daurio AM; Perkins ER; Patrick CJ; Latzman RD
    Psychol Assess; 2021 Jan; 33(1):29-44. PubMed ID: 33151728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a prominent genetic basis for associations between psychoneurometric traits and common mental disorders.
    Venables NC; Hicks BM; Yancey JR; Kramer MD; Nelson LD; Strickland CM; Krueger RF; Iacono WG; Patrick CJ
    Int J Psychophysiol; 2017 May; 115():4-12. PubMed ID: 27671504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprint of: Using a co-twin control design to evaluate alternative trait measures as indices of liability for substance use disorders.
    Joyner KJ; Yancey JR; Venables NC; Burwell SJ; Iacono WG; Patrick CJ
    Int J Psychophysiol; 2021 May; 163():58-66. PubMed ID: 33685652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Personality Psychopathology-Five (PSY-5): recent constructive replication and assessment literature review.
    Harkness AR; Finn JA; McNulty JL; Shields SM
    Psychol Assess; 2012 Jun; 24(2):432-43. PubMed ID: 21988184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a computerized adaptive screening tool for overall psychopathology ("p").
    Moore TM; Calkins ME; Satterthwaite TD; Roalf DR; Rosen AFG; Gur RC; Gur RE
    J Psychiatr Res; 2019 Sep; 116():26-33. PubMed ID: 31176109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Assessment of Personality Comparable in Persons Who Have and Have Not Experienced Depressive, Anxiety, and Substance Use Disorders? An Examination of Measurement Invariance.
    Olino TM; Benini L; Icenogle G; Wilson S; Klein DN; Seeley JR; Lewinsohn PM
    Assessment; 2019 Jan; 26(1):45-55. PubMed ID: 28799407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.